These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31166401)

  • 1. Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology.
    Magalhães RF; Rivitti-Machado MC; Duarte GV; Souto R; Nunes DH; Chaves M; Hirata SH; Ramos AMC
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):7-19. PubMed ID: 31166401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automatic International Hidradenitis Suppurativa Severity Score System (AIHS4): A novel tool to assess the severity of hidradenitis suppurativa using artificial intelligence.
    Hernández Montilla I; Medela A; Mac Carthy T; Aguilar A; Gómez Tejerina P; Vilas Sueiro A; González Pérez AM; Vergara de la Campa L; Luna Bastante L; García Castro R; Alfageme Roldán F
    Skin Res Technol; 2023 Jun; 29(6):e13357. PubMed ID: 37357665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert consensus on unmet needs, referral criteria and treatment goals for hidradenitis suppurativa in Saudi Arabia.
    Eshmawi MT; Yousef Al-Mudaiheem H; Fatani M; Binamer Y; Alajlan M; Alharithy R; Alotaibi H; Almohanna HM; Alsantali A; Madani A; Al-Faraidy N; Bechara FG; Hamden Al-Jedaie A
    J Dermatolog Treat; 2024 Dec; 35(1):2353693. PubMed ID: 38862417
    [No Abstract]   [Full Text] [Related]  

  • 5. Hidradenitis suppurativa: Impact of the French guidelines on dermatology practices.
    Fottorino A; Richard MA; Prouteau C; Balland C; Villani AP; Buche S; Hotz C; Delage M; Nassif A; Cogrel O; Jouan N
    Ann Dermatol Venereol; 2023 Sep; 150(3):227-229. PubMed ID: 36894389
    [No Abstract]   [Full Text] [Related]  

  • 6. [CME Dermatology 23/Answers: Hidradenitis suppurativa].
    Dahmen RA; Lautenschlager S
    Praxis (Bern 1994); 2021 Jun; 110(8):471-472. PubMed ID: 34107755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
    Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
    J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study.
    Needham M; Pichardo R; Alavi A; Chang AY; Daveluy S; DeNiro KL; Dewan A; Eshaq M; Fox L; Hsiao JL; Kaffenberger BH; Kirby JS; Kroshinsky D; Ortega-Loayza AG; Manusco JB; Micheletti RG; Mostaghimi A; Nelson CA; Pasieka HB; Porter ML; Resnik BI; Sayed CJ; Shi VY; Shields BE; Strowd LC
    Cutis; 2024 Jun; 113(6):251-254. PubMed ID: 39082985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum.
    Lyons AB; Peacock A; McKenzie SA; Jacobsen G; Naik HB; Shi VY; Hamzavi IH; Hsiao JL
    JAMA Dermatol; 2020 Jun; 156(6):681-685. PubMed ID: 32347884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Utilization of the Dermatology Ambulatory Encounter among Patients with Hidradenitis Suppurativa: A Population-Based Retrospective Cohort Analysis in the USA.
    Garg A; Lavian J; Strunk A
    Dermatology; 2017; 233(5):396-398. PubMed ID: 28954266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuscan consensus on the diagnosis and treatment of hidradenitis suppurativa.
    Prignano F; Pescitelli L; Giani I; Dini V; Romanelli M;
    J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():21-24. PubMed ID: 31535762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.
    Hunger RE; Laffitte E; Läuchli S; Mainetti C; Mühlstädt M; Schiller P; Lapointe AK; Meschberger P; Navarini AA
    Dermatology; 2017; 233(2-3):113-119. PubMed ID: 28683447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology.
    Bertolotti A; Sbidian E; Join-Lambert O; Bourgault-Villada I; Moyal-Barracco M; Perrot P; Jouan N; Yordanov Y; Sidorkiewicz S; Chazelas K; Bru-Daprés MF; Caumes E; Sei JF; ; Chosidow O; Beylot-Barry M;
    Br J Dermatol; 2021 May; 184(5):963-965. PubMed ID: 33278829
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
    Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018.
    Ingram JR; Collier F; Brown D; Burton T; Burton J; Chin MF; Desai N; Goodacre TEE; Piguet V; Pink AE; Exton LS; Mohd Mustapa MF
    Br J Dermatol; 2019 May; 180(5):1009-1017. PubMed ID: 30552762
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018.
    Posso-De Los Rios CJ; Sarfo A; Ghias M; Alhusayen R; Hamzavi I; Lowes MA; Alavi A
    Exp Dermatol; 2019 Jul; 28(7):769-775. PubMed ID: 30924968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive approach to managing hidradenitis suppurativa patients.
    Collier EK; Hsiao JL; Shi VY; Naik HB
    Int J Dermatol; 2020 Jun; 59(6):744-747. PubMed ID: 32250448
    [No Abstract]   [Full Text] [Related]  

  • 18. Hidradenitis Suppurativa: A Case Study.
    Schulman ML; Pantuso HM
    J Pediatr Health Care; 2015; 29(4):364-70. PubMed ID: 25575404
    [No Abstract]   [Full Text] [Related]  

  • 19. [Guidelines for the Management of Patients with Hidradenitis Suppurativa].
    Cabete J; Aparício Martins I
    Acta Med Port; 2023 Feb; 36(2):133-139. PubMed ID: 36738185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life in Hidradenitis Suppurativa: validation of the HSQoL-24.
    Marron SE; Gomez-Barrera M; Tomas Aragones L; Goni-Navarro A; Vilarrasa-Rull E; Diaz-Diaz RM; Garcia-Latasa de Aranibar FJ; Campos-Rodenas R; Fuentelsaz Del Barrio V; Gilaberte-Calzada Y; Gracia-Cazaña T; Morales-Callaghan AM; Ros-Abarca S; Madrid-Alvarez MB; Puig L
    Acta Derm Venereol; 2021 Aug; 101(8):adv00529. PubMed ID: 34427316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.